PFIZER-ALLERGAN – THE RISE AND FALL OF A MEGA-MERGER Harvard Case Solution & Analysis

PFIZER-ALLERGAN – THE RISE AND FALL OF A MEGA-MERGER Case Solution

The deal cost of USD363.63 per Allergan share equates into a 27% pemium for Allergan investors and an overall business worth for Allergan of about USD160 billion. Regardless of the reality that the offer has the possible to alter the affordable landscape of the general market, monetary experts discuss the unfavorable stock-market action with the offer being ill-timed. Therefore, Pfizer prepared a so-called inversion offer intending at the moving of head office to foreign tax programs in order to decrease the efficient business tax rate

This is just an excerpt. This case is about Business

Other Similar Case Solutions like

PFIZER-ALLERGAN – THE RISE AND FALL OF A MEGA-MERGER

Share This